Coeptis Therapeutics (ZSQR) News Today $8.98 0.00 (0.00%) As of 05/22/2026 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZSQR Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period Coeptis Therapeutics (NASDAQ:ZSQR) Trading 10% Higher - Still a Buy?May 23 at 2:21 AM | americanbankingnews.comZ Squared, Inc. Outlines Phase 1 Plan to Reach 100 MW of AI-Ready Infrastructure for Inference WorkloadsMay 19, 2026 | prnewswire.comZ Squared Appoints Jon Najarian, Pete Najarian, Marc LoPresti and Jay Zapata to Newly Formed Advisory BoardMay 4, 2026 | prnewswire.comCoeptis Therapeutics Holdings, Inc. (NASDAQ:ZSQR) Sees Large Increase in Short InterestMay 1, 2026 | marketbeat.comZ Squared to Acquire Skycore Digital, Adding 24 MW of Energized AI Infrastructure with Expansion Path to 42 MWApril 29, 2026 | prnewswire.comZ Squared, Inc. to Ring the Nasdaq Closing Bell in Celebration of Its Listing on the Nasdaq Global MarketApril 28, 2026 | prnewswire.comCoeptis Therapeutics Announces Approval of Z Squared Inc.'s Nasdaq Listing ApplicationApril 27, 2026 | finanznachrichten.deZ Squared Provides Additional Information on Previously Disclosed Pro Rata DistributionApril 27, 2026 | tmcnet.comCoeptis Therapeutics Receives Shareholder Approval Towards Z Squared MergerApril 27, 2026 | finanznachrichten.deZ Squared Inc.: Z Squared Announces Completion of Business Combination with Coeptis Therapeutics and Listing on the Nasdaq Global MarketApril 25, 2026 | finanznachrichten.deZ Squared Announces Completion of Business Combination with Coeptis Therapeutics and Listing on the Nasdaq Global MarketApril 24, 2026 | prnewswire.comCoeptis Therapeutics: Coeptis Announces Approval of Z Squared Inc.'s Nasdaq Listing ApplicationApril 9, 2026 | finanznachrichten.deCoeptis Announces Approval of Z Squared Inc.’s Nasdaq Listing ApplicationApril 7, 2026 | markets.businessinsider.comNasdaq Approves Listing for Coeptis Therapeutics Holdings, Inc. Post-Merger with Z Squared Inc.April 7, 2026 | quiverquant.comQCoeptis Announces Approval of Z Squared Inc.'s Nasdaq Listing ApplicationApril 7, 2026 | globenewswire.comCoeptis Therapeutics: Vanderbilt Report: Coeptis / Z Squared Merger Enters Final Stretch - Closing Imminent as Institutional Tailwinds BuildMarch 9, 2026 | finanznachrichten.deVanderbilt Report: Coeptis / Z Squared Merger Enters Final Stretch - Closing Imminent as Institutional Tailwinds BuildMarch 9, 2026 | finance.yahoo.comCoeptis Therapeutics: Coeptis Receives Shareholder Approval Towards Z Squared MergerFebruary 6, 2026 | finanznachrichten.deCoeptis Receives Shareholder Approval Towards Z Squared MergerFebruary 5, 2026 | globenewswire.comVanderbilt Report: Coeptis Therapeutics Shareholders Approve Transformational Merger: From Biopharma to Dual-Sector PlatformFebruary 4, 2026 | marketwatch.comCoeptis Therapeutics Addresses Nasdaq Listing Compliance DeficiencyJanuary 16, 2026 | tipranks.comCoeptis Therapeutic Holdings Details $835M Transaction Structure with Z-Squared; Vanderbilt Report Publishes CoverageJanuary 6, 2026 | finanznachrichten.deCoeptis Therapeutics Holdings, Inc. Announces SEC Approval of Merger Registration Statement with Z Squared Inc.January 6, 2026 | quiverquant.comQCoeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z SquaredJanuary 6, 2026 | globenewswire.comThree Biotech Companies Redefining Value Creation Through Dual StrategiesOctober 14, 2025 | finance.yahoo.comCoeptis Anchors $800M Valuation in Dual-Sector Strategy; Vanderbilt Report Publishes CoverageOctober 1, 2025 | finance.yahoo.comVanderbilt Report: Coeptis Shows How Biotech Can Fund Itself While InnovatingSeptember 23, 2025 | globenewswire.comCoeptis Therapeutics Holdings, Inc. Announces Extinguishment of Convertible Note, Strengthening Capital StructureJuly 22, 2025 | quiverquant.comQCoeptis (COEP) Extinguishes Convertible Note with YA II PN, LtdJuly 22, 2025 | globenewswire.comCoeptis Therapeutics Holdings, Inc. (COEPW) - Yahoo FinanceJuly 8, 2025 | finance.yahoo.comCoeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared - MorningstarJune 27, 2025 | morningstar.comMCoeptis Therapeutics Files Form S-4 Registration Statement for Proposed Merger with Z Squared Inc. - NasdaqJune 27, 2025 | nasdaq.comCoeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z SquaredJune 26, 2025 | globenewswire.comSNAP Biosciences licenses Monarch’s cell therapy techMay 29, 2025 | investing.comMonarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in OncologyMay 28, 2025 | globenewswire.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RGLS, KRON, PPBI, COEP on Behalf of ShareholdersMay 7, 2025 | morningstar.comMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COEP and PPBI on Behalf of ShareholdersMay 1, 2025 | globenewswire.comSHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Coeptis Therapeutics Holdings, Inc. - COEPApril 28, 2025 | prnewswire.comBiopharma Firm Merges With Z Squared to Form Largest Publicly-Listed Dogecoin MinerApril 26, 2025 | news.bitcoin.comCoeptis Flops on Merger with Z SquaredApril 25, 2025 | baystreet.caCOEP Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Coeptis Therapeutics Holdings, Inc. Is Fair to ShareholdersApril 25, 2025 | businesswire.comCoeptis Therapeutics Holdings, Inc. Enters Definitive Merger Agreement with Z Squared Inc. to Pursue Dogecoin Mining VentureApril 25, 2025 | quiverquant.comQCoeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger AgreementApril 25, 2025 | globenewswire.comCoeptis Therapeutics announces establishment of new technology hub in IndiaApril 18, 2025 | markets.businessinsider.comCOEPTIS Partners with NexGenAI Solutions Group to Launch New AI Co-Working Hub in India, Driving Global Innovation in TechnologyApril 17, 2025 | globenewswire.comCoeptis Therapeutics Holdings Inc. Common Stock (COEP) SEC FilingsMarch 19, 2025 | nasdaq.comCoeptis Inc. (COEP) Expands Cancer Immunotherapy Portfolio with Exclusive GEAR Cell Therapy LicenseMarch 14, 2025 | theglobeandmail.comCoeptis Therapeutics Secures Worldwide Rights To GEAR Cell Therapy PlatformMarch 13, 2025 | nasdaq.comCOEPTIS, Inc. Establishes GEAR Therapeutics to Advance Innovative Cancer Cell Therapy into First-in-Human StudiesMarch 13, 2025 | nasdaq.comCoeptis Therapeutics secures worldwide development rights to GEAR PlatformMarch 12, 2025 | markets.businessinsider.com Get Coeptis Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ZSQR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ZSQR Media Mentions By Week ZSQR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZSQR News Sentiment▼0.000.47▲Average Medical News Sentiment ZSQR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZSQR Articles This Week▼21▲ZSQR Articles Average Week Get the Latest News and Ratings for ZSQR and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Coeptis Therapeutics and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Fate Therapeutics News Voyager Therapeutics News Whitehawk Therapeutics News Unicycive Therapeutics News Innate Pharma News Tenax Therapeutics News Black Diamond Therapeutics News Aurora Cannabis News Context Therapeutics News Tiziana Life Sciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZSQR) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coeptis Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coeptis Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
